OSYPKA AG

Their core work

Osypka AG is a German medical device and electronics company specializing in cardiac stimulation systems, smart catheters, and implantable medical devices. They bring deep expertise in microfabrication, semiconductor packaging, and sensor integration — bridging the gap between advanced electronics manufacturing and clinical cardiac care. Their work spans from accelerometer-based heart monitoring to full cardiac pacing systems, positioning them as a vertically integrated player from component fabrication to finished medical products.

What they specialise in

How they've shifted over time

In their earlier H2020 participation (2015–2018), Osypka focused on medical device microfabrication and smart catheter development, working on pilot lines (InForMed) and next-generation implantables (POSITION-II). From 2019 onward, their focus split in two directions: they deepened their cardiac expertise toward a market-ready pacing system (DefiPace-System) while simultaneously broadening into semiconductor manufacturing, photonics packaging, and multi-sensor integration (APPLAUSE, Moore4Medical). This evolution suggests a company moving from component-level R&D toward full system integration and commercialization.

Osypka is transitioning from R&D participant to product owner, with their coordinated DefiPace-System project signaling a push toward market introduction of their own cardiac stimulation device.

How they like to work

Osypka primarily joins large consortia as a specialist participant (5 of 6 projects), contributing medical device and electronics packaging expertise to multi-partner pilot line initiatives. Their single coordinated project — DefiPace-System — was their largest by far (EUR 1.97M), indicating they step into leadership when commercializing their own core technology. With 133 unique partners across 19 countries, they maintain a wide European network typical of ECSEL and Innovation Action consortia.

Osypka has collaborated with 133 unique partners across 19 countries, reflecting their participation in large-scale ECSEL and Innovation Action pilot line projects. Their network spans broadly across European semiconductor and medical device ecosystems.

What sets them apart

Osypka occupies a rare intersection: they are both a medical device company (cardiac pacing, catheters) and a specialist in micro-electronics fabrication and sensor packaging. This dual expertise makes them valuable in any consortium that needs to bridge semiconductor manufacturing with clinical medical applications. For a German SME, their willingness to coordinate a nearly EUR 2M commercialization project also signals ambition and market-readiness beyond typical research participation.

Highlights from their portfolio

• DefiPace-System
  Their only coordinated project and by far the largest (EUR 1.97M) — focused on market introduction of a cardiac stimulation system, signaling commercial maturity.
• POSITION-II
  A flagship European pilot line for smart catheters and implants, placing Osypka at the center of next-generation interventional cardiology manufacturing.
• SAMBAfun
  Accelerometer-based cardiac function monitoring — an unusual sensor-to-clinical application that demonstrates their ability to integrate hardware innovation with patient outcomes.